PMC6662508_01
CT Scan showing diffuse inflammation and thickening of the meninges.
CRIOPM2019-5653282.001.jpg
PMC6662508_01_CRIOPM2019-5653282.001.jpg
fig1
C-reactive protein (CRP), indicating an underlying inflammatory process. Computer tomography (CT) scan of the head showed diffuse inflammation and thickening of the meninges (Figure 1).
External photo of the left eye following synechiolysis with pigmentary ring on the anterior lens capsule.
CRIOPM2019-5653282.002.jpg
PMC6662508_01_CRIOPM2019-5653282.002.jpg
fig2
The right eye showed posterior synechiae with pigment on the anterior lens capsule (Figure 2) while the left eye showed synechiolysis with a residual pigmentary ring on the anterior lens capsule (Figure 3).
External photo of the right eye demonstrating posterior synechiae with pigment on the anterior lens capsule.
CRIOPM2019-5653282.003.jpg
PMC6662508_01_CRIOPM2019-5653282.003.jpg
fig3
The right eye showed posterior synechiae with pigment on the anterior lens capsule (Figure 2) while the left eye showed synechiolysis with a residual pigmentary ring on the anterior lens capsule (Figure 3).
Fundus photo of the left eye demonstrating optic nerve head edema with flame hemorrhages along the inferior vascular arcade (white arrows).
CRIOPM2019-5653282.004.jpg
PMC6662508_01_CRIOPM2019-5653282.004.jpg
fig4
He was found to have increased ocular inflammation with persistent anterior chamber cells and subsequent vitreitis and bilateral optic nerve head edema in both eyes (Figures 4 and 5).
Fundus photo of the right eye demonstrating optic nerve head edema.
CRIOPM2019-5653282.005.jpg
PMC6662508_01_CRIOPM2019-5653282.005.jpg
fig5
He was found to have increased ocular inflammation with persistent anterior chamber cells and subsequent vitreitis and bilateral optic nerve head edema in both eyes (Figures 4 and 5).
OCT Macula of the left eye demonstrating para-foveal macular thickening.
CRIOPM2019-5653282.006.jpg
PMC6662508_01_CRIOPM2019-5653282.006.jpg
fig6
Optical coherence tomography (OCT) was normal in the right eye but showed subclinical parafoveal thickening in the left eye (Figure 6).
Fundus fluorescein angiography of the left eye showing para-foveal late vascular leakage (white arrows) and blockage from flame-hemorrhages.
CRIOPM2019-5653282.007.jpg
PMC6662508_01_CRIOPM2019-5653282.007.jpg
fig7
Fundus fluorescein angiography (FFA) confirmed posterior retinal involvement with bilateral parafoveal late vascular staining (Figures 7 and 8).
Fundus fluorescein angiography of the right eye showing para-foveal late vascular leakage (white arrows).
CRIOPM2019-5653282.008.jpg
PMC6662508_01_CRIOPM2019-5653282.008.jpg
fig8
Fundus fluorescein angiography (FFA) confirmed posterior retinal involvement with bilateral parafoveal late vascular staining (Figures 7 and 8).
Fundus photo of the left eye after treatment showing resolution of the optic nerve head edema.
CRIOPM2019-5653282.009.jpg
PMC6662508_01_CRIOPM2019-5653282.009.jpg
fig9
He was treated with high dose oral prednisone at 60 mg/day with full resolution in anterior chamber cells, optic nerve head edema (Figures 9 and 10), and OCT macular swelling (Figure 11).
Fundus photo of the right eye after treatment showing resolution of the optic nerve head edema.
CRIOPM2019-5653282.010.jpg
PMC6662508_01_CRIOPM2019-5653282.010.jpg
fig10
He was treated with high dose oral prednisone at 60 mg/day with full resolution in anterior chamber cells, optic nerve head edema (Figures 9 and 10), and OCT macular swelling (Figure 11).
OCT Macula of the left eye after treatment demonstrating improved para-foveal macular thickening.
CRIOPM2019-5653282.011.jpg
PMC6662508_01_CRIOPM2019-5653282.011.jpg
fig11
He was treated with high dose oral prednisone at 60 mg/day with full resolution in anterior chamber cells, optic nerve head edema (Figures 9 and 10), and OCT macular swelling (Figure 11).